I am a senior professor in Cardiology since 2013 and I have devoted my life to research in the area of Heart Failure and have up to now participated in about 310 original scientific publications and still today I am participating in about 40 different research projects, mostly epidemiological ones based on the 130 000 unique patients with Heart Failure registered in the Swedish Heart Failure Registry (SwedeHF), which I created 2003 and which is today wellknown among heart failure researchers all over the world.
Today I am also responsible for a National project called 鈥淩esponders and nonresponders in patients with heart failure鈥� in Sweden in which we build up a substantial Biobank in patients with heart failure in close connection with the SwedeHF registry.
I am also in the scientific committ茅 of the first registry randomized heart failure trial (SpirritHF) where we study the effect of spironolactone on mortality/morbidity on top of the conventional treatment or not in patients with preserved heart failure. I am still research fellow of the European Society of Cardiology (FESC) as well as research fellow of the American College of Cardiology (FACC) and still partly active in both. Previously I was very active in different leading positions in the European Heart Failure Association (HFA).
Today I am also responsible for a National project called 鈥淩esponders and nonresponders in patients with heart failure鈥� in Sweden in which we build up a substantial Biobank in patients with heart failure in close connection with the SwedeHF registry.
I am also in the scientific committ茅 of the first registry randomized heart failure trial (SpirritHF) where we study the effect of spironolactone on mortality/morbidity on top of the conventional treatment or not in patients with preserved heart failure. I am still research fellow of the European Society of Cardiology (FESC) as well as research fellow of the American College of Cardiology (FACC) and still partly active in both. Previously I was very active in different leading positions in the European Heart Failure Association (HFA).